Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.
about
The role of histone demethylases in cancer therapyHistone demethylase lysine demethylase 5B in development and cancerMicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD)Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumorsAn high-throughput in vivo screening system to select H3K4-specific histone demethylase inhibitorsmiRNAs and cancer: an epigenetics view.MicroRNA-7 inhibits multiple oncogenic pathways to suppress HER2Δ16 mediated breast tumorigenesis and reverse trastuzumab resistanceReconstruction and analysis of transcription factor-miRNA co-regulatory feed-forward loops in human cancers using filter-wrapper feature selection.Histone demethylase RBP2 decreases miR-21 in blast crisis of chronic myeloid leukemia.JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells.Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.Histone Deacetylase 10 Regulates the Cell Cycle G2/M Phase Transition via a Novel Let-7-HMGA2-Cyclin A2 Pathway.An anti-let-7 sponge decoys and decays endogenous let-7 functions.Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer.Transcription factor CCAAT/enhancer binding protein alpha up-regulates microRNA let-7a-1 in lung cancer cells by direct binding.Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma.Keeping an open mind: highlights and controversies of the breast cancer stem cell theoryRegulation of microRNAs by epigenetics and their interplay involved in cancer.A microRNA network regulates proliferative timing and extracellular matrix synthesis during cellular quiescence in fibroblasts.Intratumoral heterogeneity as a therapy resistance mechanism: role of melanoma subpopulations.Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach.Histone Modifications and Cancer.JARID1B deletion induced apoptosis in Jeko-1 and HL-60 cell lines.Overexpression of microRNAs enhances recombinant protein production in Chinese hamster ovary cells.HER4 selectively coregulates estrogen stimulated genes associated with breast tumor cell proliferation.SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase.SUMO-2 Orchestrates Chromatin Modifiers in Response to DNA Damage.JARID1 Histone Demethylases: Emerging Targets in Cancer.Hsa-miR-376c-3p targets Cyclin D1 and induces G1-cell cycle arrest in neuroblastoma cellsMDHGI: Matrix Decomposition and Heterogeneous Graph Inference for miRNA-disease association prediction
P2860
Q26864687-16365484-8BEA-449D-8FF9-3CD853AE7A76Q28076257-611FEF1C-8D2D-4062-AEA5-58CF4E910E49Q28280193-48DF983F-15AC-4080-8A8E-94F347933A7FQ28302352-87F05BE2-C410-4B34-96EB-CE96980DF1F6Q28539276-FEF531D0-DC40-4F6B-944F-AF75C8C633BDQ34286618-C368098C-EECA-475B-BFBA-A71EDFBCA2B8Q34756694-AA23585F-8D42-42E9-BD89-9D8162F75A23Q35036188-06EEAE44-2FBE-4460-AC72-3BF526910477Q35176062-06C3FE8C-B511-48E3-97BD-DDCE13D6E33FQ35828666-C44A6383-30BD-4274-8394-468F6E46B132Q35930608-E5B08090-F4D7-4162-8378-B0B182E221CEQ36070032-A9F24C24-D366-470B-AB3C-B47B4CC5A2ADQ36235552-79E23726-0E09-4C4D-A8F7-67105B80623FQ36544024-9448B936-DDEB-4C91-AB90-A42BA5CA398BQ36668241-A3E84D91-2AF7-4A6F-A767-CCD241F94574Q36983854-74E32D81-A519-41F8-A8C9-2F6408A3BEE2Q37356270-96865F80-39DA-4C21-B3D8-07EEA8CC0868Q37418150-4C297F92-A3D4-4E85-9112-85EC9784A896Q37584479-7454BBE4-9C05-4FBD-A4E9-05E7398A03C6Q38041729-85A8E077-1D09-43E7-B7A2-1051F3B0BE83Q38316610-03464FC0-A954-438F-BC6E-2D194B206D23Q38796064-37AF8C63-2DCE-46D8-AB71-B51134EB5DA0Q38901731-4882EF3C-FE6C-47B8-ACA1-6DDEA0B69290Q38995916-7A5183EB-2792-4B1A-891D-F92712EDF095Q39044090-E3A3FABE-32B4-4623-AF4D-CD791A0C240FQ39106335-E5164FBB-8D31-4D7C-AB05-097627B60D74Q41836116-0C167906-89FA-46D1-A490-7D653DD9AC02Q47730101-636B81A3-F8F0-4B55-A305-AB8FC88ED9ABQ58572068-780945F2-57D5-4D75-8A5B-13716C1924C4Q58704945-18FFF8D1-2D38-4E9F-82B0-49CD76CC4D46
P2860
Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Jumonji/ARID1 B (JARID1B) prot ...... repression of microRNA let-7e.
@ast
Jumonji/ARID1 B (JARID1B) prot ...... repression of microRNA let-7e.
@en
type
label
Jumonji/ARID1 B (JARID1B) prot ...... repression of microRNA let-7e.
@ast
Jumonji/ARID1 B (JARID1B) prot ...... repression of microRNA let-7e.
@en
prefLabel
Jumonji/ARID1 B (JARID1B) prot ...... repression of microRNA let-7e.
@ast
Jumonji/ARID1 B (JARID1B) prot ...... repression of microRNA let-7e.
@en
P2093
P2860
P356
P1476
Jumonji/ARID1 B (JARID1B) prot ...... repression of microRNA let-7e.
@en
P2093
Doyel Mitra
Felicia C Huynh
Frank E Jones
Partha M Das
P2860
P304
40531-40535
P356
10.1074/JBC.M111.304865
P407
P577
2011-10-03T00:00:00Z